Mast Therapeutics Inc (NYSE MKT LLC:MSTX)

0.52
Delayed Data
As of Mar 26
 -0.001 / -0.19%
Today’s Change
0.40
Today|||52-Week Range
0.78
-7.14%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2010

2011

2012

2013
Operating ActivitiesNet Income / Starting Line-8.5M-13.3M-15.6M-21.5M
 
 
 
 
 
Depreciation19.8K37.6K90.0K39.5K
 
 
 
 
 
Total Other Cash Flow790.2K-585.1K1.8M1.6M
 
 
 
 
 
Funds From Operations-7.6M-13.8M-13.7M-19.8M
 
 
 
 
 
Funds From/For Other Operating Expenses700.3K-340.5K268.2K-2.0M
 
 
 
 
 
Net Cash Flow - Operating Activities-8.3M-13.5M-13.9M-17.8M
 
 
 
 
 
 
InvestingIncrease In Investments0.00-7.1M-15.8M-22.0M
 
 
 
 
Decrease In Investments0.000.008.9M17.2M
 
 
 
Capital Expenditures-28.5K-411.8K-266.2K-46.8K
 
 
 
 
 
Fixed Asset Disposal4.4K12.6K0.000.00
 
 
 
Net Cash Flow Investing-24.1K-7.5M-7.2M-4.8M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale27.7M36.6M2.2K25.7M
 
 
 
 
 
Common Preferred Redeemed0.000.00-1.5K0.00
 
 
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing146.000.000.000.00
 
 
Net Cash Flow - Financing27.7M36.6M740.0025.7M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash---2.2K13.8K-1.5K
 
 
 
 
 
Net Change In Cash19.3M15.6M-21.1M3.2M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account